Lixisenatide (Lyxumia®)
Specialist to initiate and stabilise dose. SCG available.
- Traffic LightAmber (G)
- BNF6.1.2.3
- Licensed IndicatorsTreatment of type 2 diabetes in combination with oral antidiabetic drugs or basal insulin or both when adeqaute glycaemic control not been achieved
- ReferenceAPC Nov 13
- Criteria
- ProvisionalNo
Do you want to add this to your CPD record?
Did you find this page helpful?